Headquarters: Petach Tikva, Israel
Investor Relations: Bob Yedid / 646-597-6989 / Bob@LifeSciAdvisors.com
Description
A Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology,
Industry
Life Sciences
Year Founded
Ownership
Public
Exchange / Symbol
NASDAQ: PUPD
Public Since
Chief Executive Officer
Chairman of the Board
Chief Financial Officer
Insider Ownership
Key Investors
Employee Count
Auditors
Investment Bankers
Law Firms
In the CEOs Own Words
Corporate Mission
Proudest Accomplishment
Next Milestone
Geographic Markets Served
Growth Drivers
Growth Headwinds
Indicia of Customer Satisfaction
Scalability
Workforce
Focus of Recruitment
Research and Development
Patent Count
Economic Sensitivity
Unique Metrics
Greatest Concern
Company Reports and Communications
SEC Filings
" target="_blank">